{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:49:58Z","timestamp":1784152198302,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.yebeh.2025.110504","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T16:51:11Z","timestamp":1748105471000},"page":"110504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Exploring neurodevelopment in CDKL5 deficiency disorder: Current insights and future directions"],"prefix":"10.1016","volume":"171","author":[{"given":"Giovanni Battista","family":"Dell\u2019Isola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Giorgia","family":"Perinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Frulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fattorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Verrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2025.110504_b0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2019.02.015","article-title":"Cyclin-dependent kinase-like 5 deficiency disorder: clinical review","volume":"97","author":"Olson","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0010","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/brain\/awz195","article-title":"Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort","volume":"142","author":"Symonds","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2025.110504_b0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejpn.2021.04.007","article-title":"CDKL5 deficiency disorder in males: five new variants and review of the literature","volume":"33","author":"Siri","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1474-4422(22)00035-7","article-title":"CDKL5 deficiency disorder: clinical features, diagnosis, and management","volume":"21","author":"Leonard","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13023-016-0418-y","article-title":"Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome","volume":"11","author":"Mangatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2025.110504_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.817195","article-title":"Sleep disorders in rett syndrome and rett-related disorders: a narrative review","volume":"13","author":"Tascini","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1152\/physrev.00063.2021","article-title":"Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum","volume":"103","author":"Guerrini","year":"2023","journal-title":"Physiol Rev"},{"key":"10.1016\/j.yebeh.2025.110504_b0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/dneu.22639","article-title":"Molecular and synaptic bases of CDKL5 disorder","volume":"79","author":"Zhu","year":"2019","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.yebeh.2025.110504_b0045","doi-asserted-by":"crossref","first-page":"30101","DOI":"10.1074\/jbc.M804613200","article-title":"CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail","volume":"283","author":"Rusconi","year":"2008","journal-title":"J Biol Chem"},{"issue":"30","key":"10.1016\/j.yebeh.2025.110504_b0050","doi-asserted-by":"crossref","first-page":"12777","DOI":"10.1523\/JNEUROSCI.1102-10.2010","article-title":"CDKL5, a protein associated with rett syndrome, regulates neuronal morphogenesis via Rac1 signaling","volume":"22","author":"Chen","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2025.110504_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02434-7","article-title":"Cell type-specific expression, regulation and compensation of CDKL5 activity in mouse brain","author":"Silvestre","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yebeh.2025.110504_b0060","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1523\/JNEUROSCI.0539-17.2017","article-title":"Loss of CDKL5 in glutamatergic neurons disrupts hippocampal microcircuitry and leads to memory impairment in mice","volume":"37","author":"Tang","year":"2017","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2025.110504_b0065","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/s41467-019-10689-w","article-title":"Altered NMDAR signalling underlies autistic-like features in mouse models of CDKL5 deficiency disorder","volume":"10","author":"Tang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.yebeh.2025.110504_b0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/epi.17125","article-title":"Influences on the trajectory and subsequent outcomes in CDKL5 deficiency disorder","volume":"63","author":"Leonard","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110504_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63570","article-title":"Communication of individuals with CDKL5 deficiency disorder as observed by caregivers: a descriptive qualitative study","volume":"194","author":"Keeley","year":"2024","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.yebeh.2025.110504_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105176","article-title":"X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder","volume":"148","author":"Terzic","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2025.110504_b0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/epi.16805","article-title":"CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures","volume":"62","author":"Wang","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110504_b0090","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1523\/JNEUROSCI.2041-18.2019","article-title":"AMPA receptor dysregulation and therapeutic interventions in a mouse model of CDKL5 deficiency disorder","volume":"39","author":"Yennawar","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2025.110504_b0095","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1038\/s41467-023-43475-w","article-title":"Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability","volume":"14","author":"Sampedro-Casta\u00f1eda","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.yebeh.2025.110504_b0100","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajhg.2018.09.006","article-title":"De novo pathogenic variants in CACNA1E cause developmental and epileptic encephalopathy with contractures, macrocephaly, and dyskinesias","volume":"103","author":"Helbig","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"231","key":"10.1016\/j.yebeh.2025.110504_b0105","article-title":"The gut-brain connection: exploring the influence of the gut microbiota on neuroplasticity and neurodevelopmental disorders","volume":"15","author":"Damiani","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2025.110504_b0110","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/cells10082084","article-title":"Gut microbiota and neuroplasticity","volume":"10","author":"Murciano-Brea","year":"2021","journal-title":"Cells"},{"issue":"20","key":"10.1016\/j.yebeh.2025.110504_b0115","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.3390\/ijms20174160","article-title":"Rett syndrome and other neurodevelopmental disorders share common changes in gut microbial community: a descriptive review","volume":"26","author":"Borghi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2025.110504_b0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00011-016-1014-2","article-title":"Inflammatory protein response in CDKL5-Rett syndrome: evidence of a subclinical smouldering inflammation","volume":"66","author":"Cortelazzo","year":"2017","journal-title":"Inflamm Res"},{"key":"10.1016\/j.yebeh.2025.110504_b0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12974-021-02204-0","article-title":"Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder","volume":"18","author":"Galvani","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.yebeh.2025.110504_b0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-neuro-110920-023056","article-title":"Microglia and neurodevelopmental disorders","volume":"45","author":"Lukens","year":"2022","journal-title":"Annu Rev Neurosci"},{"issue":"14","key":"10.1016\/j.yebeh.2025.110504_b0135","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1038\/s41598-024-56989-0","article-title":"Gut microbiota profile in CDKL5 deficiency disorder patients","volume":"28","author":"Borghi","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.yebeh.2025.110504_b0140","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/426462","article-title":"Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation","volume":"75","author":"Weaving","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"27","key":"10.1016\/j.yebeh.2025.110504_b0145","article-title":"Analysis of the phenotypes in the rett networked database","volume":"2019","author":"Frullanti","year":"2019","journal-title":"Int J Genomics"},{"key":"10.1016\/j.yebeh.2025.110504_b0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ejhg.2012.156","article-title":"The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy","volume":"21","author":"Fehr","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.yebeh.2025.110504_b0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1866-1955-7-2","article-title":"There is variability in the attainment of developmental milestones in the CDKL5 disorder","volume":"7","author":"Fehr","year":"2015","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.yebeh.2025.110504_b0160","first-page":"151","article-title":"CDKL5 mutations in early onset epilepsy: case report and review of the literature","volume":"1","author":"Olson","year":"2012","journal-title":"J Pediatr Epilep"},{"key":"10.1016\/j.yebeh.2025.110504_b0165","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1399-0004.2009.01194.x","article-title":"Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literature","volume":"76","author":"Nemos","year":"2009","journal-title":"Clin Genet"},{"key":"10.1016\/j.yebeh.2025.110504_b0170","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1086\/426460","article-title":"Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5\/STK9) gene are associated with severe neurodevelopmental retardation","volume":"75","author":"Tao","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yebeh.2025.110504_b0175","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1093\/brain\/awn197","article-title":"Key clinical features to identify girls with CDKL5 mutations","volume":"131","author":"Bahi-Buisson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2025.110504_b0180","first-page":"130","article-title":"Caregiver's perception of epilepsy treatment, quality of life and comorbidities in an international cohort of CDKL5 patients","volume":"21","author":"Amin","year":"2017","journal-title":"Hippokratia"},{"key":"10.1016\/j.yebeh.2025.110504_b0185","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1002\/ajmg.a.37851","article-title":"Functional abilities in children and adults with the CDKL5 disorder","volume":"170","author":"Fehr","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.yebeh.2025.110504_b0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41431-022-01163-1","article-title":"Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder","volume":"31","author":"Wong","year":"2023","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.yebeh.2025.110504_b0195","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1212\/WNL.0000000000003352","article-title":"Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder","volume":"87","author":"Fehr","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110504_b0200","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1007\/s10803-023-06002-w","article-title":"Validating the communication and symbolic behavior scales-developmental profile infant-toddler checklist (CSBS-DP ITC) beyond infancy in the CDKL5 deficiency disorder","volume":"54","author":"Saldaris","year":"2024","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2025.110504_b0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/08830738221091044","article-title":"Initial Validation and reliability of the CDKL5 deficiency disorder hand function scale (CDD-Hand)","volume":"37","author":"Saldaris","year":"2022","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pediatrneurol.2019.03.017","article-title":"Severity assessment in CDKL5 deficiency disorder","volume":"97","author":"Demarest","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0215","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/08830738211019576","article-title":"Content validation of clinician-reported items for a severity measure for CDKL5 deficiency disorder","volume":"36","author":"Saldaris","year":"2021","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107231","article-title":"The development, content and response process validation of a caregiver-reported severity measure for CDKL5 deficiency disorder","volume":"197","author":"Ziniel","year":"2023","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2025.110504_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107287","article-title":"Adapting a measure of gross motor skills for individuals with CDKL5 deficiency disorder: a psychometric study","volume":"200","author":"Saldaris","year":"2024","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2025.110504_b0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14737175.2023.2176221","article-title":"Learnings in developmental and epileptic encephalopathies: what do we know?","volume":"23","author":"Perinelli","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2025.110504_b0235","first-page":"268","article-title":"Mental retardation in pediatric candidates for epilepsy surgery: the role of early seizure onset","volume":"42","author":"Vasconcellos","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110504_b0240","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1528-1167.2007.01520.x","article-title":"The three stages of epilepsy in patients with CDKL5 mutations","volume":"49","author":"Bahi-Buisson","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110504_b0245","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1212\/WNL.0b013e3182166e58","article-title":"A distinctive seizure type in patients with CDKL5 mutations: Hypermotor-tonic-spasms sequence","volume":"76","author":"Klein","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110504_b0250","article-title":"CDKL5 deficiency-related neurodevelopmental disorders: a multi-center cohort study in Italy","author":"Dell'Isola","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0255","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/dmcn.14908","article-title":"Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure","volume":"63","author":"Olson","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0260","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/08830738211019284","article-title":"Cerebral visual impairment in CDKL5 deficiency disorder correlates with developmental achievement","volume":"36","author":"Brock","year":"2021","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0265","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/eye.2012.154","article-title":"Reliability of a question inventory for structured history taking in children with cerebral visual impairment","volume":"26","author":"Macintyre-Beon","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.yebeh.2025.110504_b0270","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0031-1285908","article-title":"Screening for cerebral visual impairment: value of a CVI questionnaire","volume":"42","author":"Ortibus","year":"2011","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2025.110504_b0275","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac197","article-title":"Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder","volume":"4","author":"Saby","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.yebeh.2025.110504_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.805745","article-title":"Cortical visual impairment in CDKL5 deficiency disorder","volume":"12","author":"Quintiliani","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/cge.13862","article-title":"Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset","volume":"99","author":"MacKay","year":"2021","journal-title":"Clin Genet"},{"key":"10.1016\/j.yebeh.2025.110504_b0290","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/gim.2017.114","article-title":"High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders","volume":"20","author":"Stosser","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.yebeh.2025.110504_b0295","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/ajmg.a.35401","article-title":"Recurrent mutations in the CDKL5 gene: genotype-phenotype relationships","volume":"158A","author":"Bahi-Buisson","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.yebeh.2025.110504_b0300","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11689-021-09384-z","article-title":"Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder","volume":"13","author":"Olson","year":"2021","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.yebeh.2025.110504_b0305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1474-4422(22)00077-1","article-title":"Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial","volume":"21","author":"Knight","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0310","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/epi.16923","article-title":"Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder","volume":"62","author":"Devinsky","year":"2021","journal-title":"Epilepsia"},{"issue":"13","key":"10.1016\/j.yebeh.2025.110504_b0315","article-title":"Improving therapy of pharmacoresistant epilepsies: the role of fenfluramine","volume":"20","author":"Dini","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.yebeh.2025.110504_b0320","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejpn.2024.06.005","article-title":"Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial","volume":"51","author":"Downs","year":"2024","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110504_b0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2019.02.001","article-title":"Cannabis for refractory epilepsy in children: a review focusing on CDKL5 deficiency Disorder","volume":"151","author":"Dale","year":"2019","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2025.110504_b0330","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/17425255.2024.2329733","article-title":"Cannabidiol: metabolism and clinical efficacy in epileptic patients","volume":"20","author":"Dell'Isola","year":"2024","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.yebeh.2025.110504_b0335","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/ejn.16350","article-title":"Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5R59X knock-in mice","volume":"59","author":"Li","year":"2024","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.yebeh.2025.110504_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109173","article-title":"Efficacy, safety, and tolerability of soticlestat as adjunctive therapy for the treatment of seizures in patients with Dup15q syndrome or CDKL5 deficiency disorder in an open-label signal-finding phase II study (ARCADE)","volume":"142","author":"Demarest","year":"2023","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110504_b0345","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/hmg\/ddy064","article-title":"CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder","volume":"27","author":"Trazzi","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yebeh.2025.110504_b0350","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/brain\/awaa028","article-title":"Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder","volume":"143","author":"Gao","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2025.110504_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107746","article-title":"Pharmacotherapy with sertraline rescues brain development and behaviour in a mouse model of CDKL5 deficiency disorder","volume":"167","author":"Fuchs","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2025.110504_b0360","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.3390\/ijms22115950","article-title":"Treatment with a GSK-3\u03b2\/HDAC dual inhibitor restores neuronal survival and maturation in an in vitro and in vivo model of CDKL5 deficiency disorder","volume":"22","author":"Loi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2025.110504_b0365","unstructured":"University of Milan (sponsor). Targeting the Gut to Improve Seizure Control in CDKL5 Deficiency Disorder (CDD) (NUTRIENT) (ClinicalTrials.gov Identifer: NCT06448663) (last update posted on 2024-06-07)."},{"key":"10.1016\/j.yebeh.2025.110504_b0370","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200287","article-title":"Early developmental intervention and enriched environment in CDKL5 developmental and epileptic encephalopathy: a case report","volume":"14","author":"Perinelli","year":"2024","journal-title":"Neurol Clin Pract"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025002434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025002434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:12:32Z","timestamp":1778616752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505025002434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":74,"alternative-id":["S1525505025002434"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110504","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring neurodevelopment in CDKL5 deficiency disorder: Current insights and future directions","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110504"}}